675Wire StoriesIndia Live Event Market Report 2020: Ticketed Events, Event Category, Future Outlook, Event Offerings in Percent – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India Live Event Market, Ticketed Events, Event Category, Future Outlook, Event Offerings in Percent” report has been added to ResearchAndMarkets.com’s...
- 757Wire Stories
Kulicke & Soffa Declares Regular Quarterly Dividend of $0.12
SINGAPORE–(BUSINESS WIRE)–Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) (“Kulicke & Soffa,” “K&S” or the “Company”), announced today that its Board of Directors...
- 747Wire Stories
Kulicke & Soffa Appoints Jeff Richardson to its Board of Directors
SINGAPORE–(BUSINESS WIRE)–Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) (“Kulicke & Soffa,” “K&S” or the “Company”) today announced the appointment of David Jeffrey...
- 764Wire Stories
KartRider Rush+ Surpasses 10 Million Global Downloads Within Two Weeks!
Nexon’s Thrilling Mobile Racer Adds Three New Tracks and New Character ‘Dino Ethen’ LOS ANGELES–(BUSINESS WIRE)–#kartracer–Let’s go full throttle! Today, Nexon announced...
- 766Wire Stories
TriLinc Global Impact Fund Makes Impact Investment in Latin America
TriLinc Global Impact Fund announced today that it recently approved a $3,250,000 term loan transaction, bringing total financing commitments as of April...
- 689Wire Stories
COVID-19 Case Study: Retailers Reactions in China 2020 – Lin Qingxuan, Nike, Meituan Dianping, JD.com, Alibaba, and Hema – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retailer Reactions in China: Coronavirus (COVID-19) – Case Study” report has been added to ResearchAndMarkets.com’s offering. This brief looks at...
- 714Wire Stories
Impact of COVID-19 on the Retail Sector in China, 2020 – Consumer Behaviour and Purchasing Patterns on Food, Non-Food, Drinks and Personal Care – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retail in China: Coronavirus (COVID-19) Country impact” report has been added to ResearchAndMarkets.com’s offering. The Coronavirus (COVID-19) country report analyses...
- 724Wire Stories
Takeda to Present Data from the ICLUSIG® (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML
– Oral Presentations of the Phase 2 OPTIC Interim Analysis at the American Society of Clinical Oncology (ASCO) and the European Hematology...
- 787Wire Stories
Takeda Announces Compelling Data from the Phase 2 Trial of Pevonedistat Plus Azacitidine in Patients with Higher-Risk MDS
– Pevonedistat Combination Demonstrates the Potential to Double Complete Remissions and Improve Outcomes in HR-MDS, With Safety Profile Similar to Azacitidine Alone...
- 818Wire Stories
Daiichi Sankyo Announces Clinical Research Collaboration to Evaluate DS-1062 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Non-Small Cell Lung Cancer
TOKYO & MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that it has entered into a clinical...
